COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution

Debabrata Mukherjee, MD
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor

Steven E. Nissen, MD
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology,  Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Debabrata Mukherjee, MD, Assistant Professor, Division of Cardiology, University of Michigan Health System, University Hospital, B1-F245, 1500 E Medical Center Drive, Ann Arbor, MI 48103-0022; dmukherj@umich.edu

Debabrata Mukherjee, MD
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor

Steven E. Nissen, MD
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology,  Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Debabrata Mukherjee, MD, Assistant Professor, Division of Cardiology, University of Michigan Health System, University Hospital, B1-F245, 1500 E Medical Center Drive, Ann Arbor, MI 48103-0022; dmukherj@umich.edu

Debabrata Mukherjee, MD
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor

Steven E. Nissen, MD
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology,  Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Debabrata Mukherjee, MD, Assistant Professor, Division of Cardiology, University of Michigan Health System, University Hospital, B1-F245, 1500 E Medical Center Drive, Ann Arbor, MI 48103-0022; dmukherj@umich.edu